Real-time enrollment status for this macular edema clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 2:32 AM UTC
| NCT Number | NCT06990399 |
| Recruiting Status | Recruiting |
| Condition | Macular Edema |
| Phase | PHASE3 |
| Target Enrollment | 600 participants |
| Active Locations | 55 sites in the US |
| Sponsor | Kodiak Sciences Inc |
| Last Updated on CT.gov | May 18, 2026 (May 18, 2026) |
As of August 31, 2026: Clinical trial NCT06990399 is currently recruiting participants. This phase3 study for macular edema is actively seeking new participants at 55 locations across the United States. The study is sponsored by Kodiak Sciences Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06990399 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 55 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06990399 was last updated May 18, 2026 (May 18, 2026). HelloStudys verifies this status automatically.